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In outbred Western populations, most individuals with intellectual disability (ID) are sporadic
cases, dominant de novo mutations (DNM) are frequent, and autosomal recessive ID (ARID) is
very rare. Because of the high rate of parental consanguinity, which raises the risk for ARID and
other recessive disorders, the prevalence of ID is significantly higher in near- and middle-east
countries. Indeed, homozygosity mapping and sequencing in consanguineous families have
already identified a plethora of ARID genes, but because of the design of these studies, DNMs
could not be systematically assessed, and the proportion of cases that are potentially prevent-
able by avoiding consanguineous marriages or through carrier testing is hitherto unknown. This
prompted us to perform whole-exome sequencing in 100 sporadic ID patients from Iran and
their healthy consanguineous parents. In 61 patients, we identified apparently causative changes
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in known ID genes. Of these, 44 were homozygous recessive and 17 dominant DNMs. Assuming
that the DNM rate is stable, these results suggest that parental consanguinity raises the ID risk
about 3.6-fold, and about 4.1 to 4.25-fold for children of first-cousin unions. These results do
not rhyme with recent opinions that consanguinity-related health risks are generally small and
have been “overstated” in the past.
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1 | INTRODUCTION
Parental consanguinity (PC) is known to raise the risk of having chil-
dren with recessive disorders, and it is associated with increased pre-
natal and pre-reproductive mortality. In the offspring of first-cousin
matings, the prevalence of major congenital malformations (CM) is 2%
to 2.5% higher than in children of unrelated parents; in Western coun-
tries, this more than doubles the CM risk (1–5 and refs therein). More-
over, 3- to 5-fold elevated intellectual disability (ID) risks have been
reported for children whose parents are first cousins,6–10 but these
estimates are based on few and mostly small studies with different
designs, rendering direct comparisons difficult.
PC and autosomal recessive forms of ID (ARID) are rare in most
parts of Europe and the United States, where the vast majority of ID
patients are sporadic cases and dominant de novo mutations (DNMs)
are common.11–13 In contrast, PC is common in many developing
countries, from Morocco through the near- and middle-east to parts
of India (see Ref. 14), with current consanguinity rates being highest
in Pakistan and Sudan. Recessive disorders are also a major health
care problem in many other countries of the so-called “consanguinity
belt,” including Iran and, for example, Qatar, where a 30-year health
plan aims to reduce the frequency of consanguineous matings.15
As shown a decade ago,16 ARID is extremely heterogeneous, and
the number of causative genes is likely to run into thousands.17 This
has been confirmed by large-scale, high-throughput sequencing in
consanguineous families with two or more intellectually disabled chil-
dren (see Ref. 18 and refs therein): between the first and the most
recent study of this kind,18,19 the percentage of multiplex families
with mutations in known ARID genes has only risen from one-third to
about one half18 while the number of known ARID genes has
increased from about a dozen to about 800 today.18,20,21
In a recent study of the British Deciphering Developmental
Defects (DDD) project,22 whole-exome sequencing (WES) identified
bi-allelic (recessive) mutations in 3.6% of the patients with develop-
mental disorders (DD) and European ancestry, compared to 49.9%
DNMS in known DD genes. To date, no comparable molecular data
have been published for countries where PC is common, because
most sequencing studies performed in Iran, Turkey, Saudi Arabia or
Pakistan focused on recessive gene defects and were not designed to
capture DNM (eg,19–21), did not quantify consanguinity or autozygos-
ity, or were simply too small23.
Therefore, and in view of persisting disputes about the size of
health care risks conferred by PC and the appropriateness and effi-
ciency of efforts to discourage consanguineous matings (eg, see
Refs. 24 and 25), we present here the results of molecular investiga-
tions designed to infer the proportion of DNM and recessive inherited
mutations causing ID in the offspring of healthy consanguineous par-
ents. These data provide a backbone for estimating preventable ID
risks, in countries where PC is common and world-wide.
2 | MATERIAL AND METHODS
2.1 | Patients
The study was approved by the Ethics Committee of the University of
Social Welfare and Rehabilitation, Tehran, Iran. Consent for participa-
tion of their child in this study was obtained from at least one of the
parents and if possible, from the patients themselves.
Families with a single intellectually disabled child and healthy con-
sanguineous parents were recruited from different provinces of Iran,
who had been pre-screened to exclude chromosomal rearrangements
as well as fragile X syndrome. In total, 100 unrelated ID patients and
their parents were included in this study. All underwent a comprehen-
sive clinical examination by experienced clinical geneticists. To deter-
mine the intelligence quotient (IQ) of children and their parents, we
used Wechsler Intelligence Scales for Children (WISC) and adults
(WAIS). Clinical findings in affected children are provided in Table 1
and Table S1.
2.2 | Whole-exome sequencing and array-
comparative genomic hybridization
We extracted genomic DNA from white blood cells of patients and
parents, enriched exomic sequences with the Agilent SureSelectXT
Human All Exon V5 enrichment kit, performed 100 bp paired-end
sequencing on an Illumina HiSeq sequencer and employed the MERAP
pipeline for sequence analysis, as previously described.18,26
Previous studies16,19 had shown that in consanguineous ARID
families, microdeletions or duplications are very rare, and that the
analysis of WES data with our previously described MERAP pipeline26
identifies most clinically relevant homozygous copy number variants
(CNVs). Therefore, array-based comparative genomic hybridization
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